Anavex Life Sciences Corp.
630 5th Avenue
New York
New York
10111
United States
Tel: 1-844-689-3939
Website: http://www.anavex.com/
Email: info@anavex.com
363 articles about Anavex Life Sciences Corp.
-
Anavex Life Sciences Corp. Comments on President Obama's National Plan to Fight Alzheimer's Disease
5/30/2012
-
Anavex Life Sciences Corp. to Present Corporate Update at Biotechnology Industry Organization (BIO) CEO & Investor Conference
2/14/2012
-
Anavex Life Sciences Corp. Successfully Completes a Phase 1 Clinical Trial for ANAVEX 2-73
11/14/2011
-
Anavex Life Sciences Corp. Appoints Dr. George Tidmarsh as Executive Director
10/12/2011
-
Anavex Life Sciences Corp. to Present Data on ANAVEX 2-73, Lead Compound for Alzheimer's Disease, at Japan Neuroscience Society Special Symposium
9/15/2011
-
Anavex Life Sciences Corp. Presents Data on Neuroprotective Evidence for ANAVEX 2-73, Lead Compound for Alzheimer's Disease
7/26/2011
-
Anavex Life Sciences Corp. presents data on neuroprotective evidence for ANAVEX 2-73, lead compound for Alzheimer's disease
7/26/2011
-
Anavex Life Sciences Corp. Presents Data on Potential Dual Utility of ANAVEX 2-73 in Both Amyloid and Tau Pathology
7/25/2011
-
Anavex Life Sciences Corp. presents data on potential dual utility of ANAVEX 2-73 in both amyloid and tau pathology
7/25/2011
-
Anavex Life Sciences Corp. to present at Alzheimer's Association International Conference on Alzheimer's Disease
7/14/2011
-
Anavex Life Sciences Corp. Raises $1.575 Million
7/11/2011
-
Anavex Life Sciences Corp. Rapidly Advances ANAVEX 2-73 For Alzheimer's Disease, Phase I Clinical Trial Progressing Well
7/6/2011
-
Anavex Life Sciences Corp. Advances Second Lead Compound; Initiates Scale-up Manufacturing of ANAVEX 1-41
6/8/2011
-
Anavex Life Sciences Corp.'S ANAVEX 2-73 advances Phase I clinical trial for Alzheimer's disease
5/23/2011
-
Anavex Life Sciences Corp. Comments on New Alzheimer's Disease Diagnostic Guidelines
5/17/2011
-
Anavex Life Sciences Corp. Appoints Robert Chisholm to Board Of Directors
5/16/2011
-
Anavex Life Sciences Corp.: First-In-Human Dosing Commenced In Anavex 2-73 Clinical Trial For Alzheimer's Disease
4/20/2011
-
Anavex Life Sciences Corp. Appoints Dr. Christopher Shackleton As An Advisor
4/8/2011
-
Anavex Life Sciences Corp. to Hold Annual Meeting On April 11, 2011
4/6/2011
-
Anavex Life Sciences Corp. Screening Healthy Volunteers For Phase I, First-In-Human Clinical Study In Alzheimer's Disease
3/31/2011